PATENT CLAIM ANALYSIS

Application Number: 15960441
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "263210"]

Abstract:
Pharmaceutical compositions comprising an antidiabetic agent as an active agent are provided. The present invention relates to pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof as an active agent. The present invention also relates to process of preparation of pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof. The present invention also relates to method of administering the compositions comprising linagliptin to a subject in need thereof.

Claim (Index 6):
The composition according to  claim 1 , comprising linagliptin in an amount less than 5.0% w/w of the total weight of the composition, mannitol in an amount about 84.0% w/w of the total weight of the composition, copovidone in an amount less than 3.0% w/w of the total weight of the composition, corn starch in an amount less than 2.0% w/w of the total weight of the composition and a coating comprising hydroxypropylmethylcellulose on the composition.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.17647
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14417992', '15767131', '13511771', '12683696', '15235575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7151726234917478
- 35 USC 102 Novelty (BERT): 0.516604741019213
- Combined Prediction Score: 0.6953158352444944
- Mean Citation Score: 260.294604
- Max Citation Score: 292.4849200000001
- Similarity Product: 188.4655324634839

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test